Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelin does not affect aggregation of human platelets.

A Edlund1, A Wennmalm

  • 1Department of Clinical Physiology, Huddinge Hospital, Sweden.

Clinical Physiology (Oxford, England)
|November 1, 1990
PubMed
Summary

Endothelin-1 (ET-1), a vasoconstrictor peptide, does not directly cause human platelet aggregation in vitro. Studies show ET-1 also fails to alter platelet aggregation induced by other agents like ADP or thrombin.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring ex vivo biofilm dynamics: consequences of low ampicillin concentrations on the human oral microbiome.

NPJ biofilms and microbiomes·2024
Same author

SCRT1 is a novel beta cell transcription factor with insulin regulatory properties.

Molecular and cellular endocrinology·2020
Same author

The Oral Host-Microbial Interactome: An Ecological Chronometer of Health?

Trends in microbiology·2020
Same author

Caries-Associated Biosynthetic Gene Clusters in <i>Streptococcus mutans</i>.

Journal of dental research·2020
Same author

Endogenous beta-cell CART regulates insulin secretion and transcription of beta-cell genes.

Molecular and cellular endocrinology·2017
Same author

Reorganization of nursing and medical care to reduce the incidence of postoperative delirium and improve rehabilitation outcome in elderly patients treated for femoral neck fractures.

Scandinavian journal of caring sciences·2002

Area of Science:

  • Cardiovascular Biology
  • Hemostasis and Thrombosis
  • Endothelial Cell Function

Background:

  • Endothelin-1 (ET-1) is a potent vasoconstrictor peptide derived from endothelial cells.
  • Vasoactive agents often influence platelet function, impacting hemostasis and thrombosis.
  • The direct effect of ET-1 on human platelet aggregation remained to be elucidated.

Purpose of the Study:

  • To investigate whether endothelin-1 (ET-1) induces or modulates human platelet aggregation in vitro.
  • To compare the effects of ET-1 on platelet aggregation with known agonists like adenosine diphosphate (ADP) and thrombin.

Main Methods:

  • Human venous blood was collected from healthy donors in citrate or heparin.
  • Platelet-rich plasma (PRP) was isolated.

Related Experiment Videos

  • Platelet aggregation was measured using the Born & Cross method after addition of ET-1, ADP, or thrombin.

    • Main Results:

    • Endothelin-1 (ET-1) did not induce platelet aggregation at concentrations ranging from 1-100 nM in both citrate and heparinized PRP.
    • ET-1 (1-100 microM) did not affect platelet aggregation induced by adenosine diphosphate (ADP) or thrombin.
    • Standard agonists (ADP and thrombin) induced dose-dependent platelet aggregation as expected.

    Conclusions:

    • Endothelin-1 (ET-1) does not possess direct platelet aggregatory activity in vitro.
    • Unlike some other vasoactive peptides, ET-1 does not directly influence the aggregation of human platelets.
    • These findings differentiate ET-1 from other endothelial-derived vasoactive agents regarding platelet interaction.